Search





Search





Markets
/
Stocks
/
fhtx
/

Foghorn Therapeutics Inc.

FHTX

Add to Watchlist

4.525USD

-0.215-4.54%

Close 07-31 16:00（ET）Quotes delayed by 15 min

265.66MMarket Cap

LossP/E TTM

Foghorn Therapeutics Inc.

4.525

-0.215-4.54%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

FHTX Cash Flow Statement

You can access the annual and quarterly cash flow statements of Foghorn Therapeutics Inc. to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-5.42%-25.27M

9.17%-22.27M

10.21%-18.86M

17.77%-21.00M

18.32%-23.97M

10.97%-24.52M

22.80%-21.00M

20.63%-25.54M

5.89%-29.34M

4.78%-27.54M

-36.15%-27.21M

-10.90%-32.17M

-111.48%-31.18M

-343.43%-28.92M

2.52%-19.99M

-56.97%-29.01M

1273.09%271.53M

211.52%11.88M

-852.09%-20.50M

---18.48M

-115.08%-23.15M

---10.65M

--2.73M

---10.76M

Net income from continuing operations

-5.53%-19.88M

-11.08%-21.66M

17.12%-15.85M

21.95%-17.94M

24.71%-18.83M

19.09%-19.50M

-33.30%-19.12M

22.07%-22.98M

17.95%-25.02M

16.55%-24.11M

44.33%-14.35M

-7.96%-29.49M

-13.28%-30.49M

0.88%-28.89M

1.19%-25.77M

-18.18%-27.31M

-17.09%-26.91M

-40.39%-29.14M

-41.99%-26.08M

---23.11M

-64.75%-22.99M

---20.76M

---18.37M

---13.95M

Operating gains losses

-71.22%238.00K

782.52%6.72M

16.23%852.00K

-73.31%851.00K

-0.96%827.00K

-10.68%761.00K

-15.16%733.00K

264.04%3.19M

-2.79%835.00K

0.47%852.00K

2.49%864.00K

6.96%876.00K

5.92%859.00K

4.69%848.00K

-2.09%843.00K

4.46%819.00K

5.05%811.00K

43.87%810.00K

237.65%861.00K

--784.00K

202.75%772.00K

--563.00K

--255.00K

Other non-cash items

-72.58%173.00K

-889.36%-1.40M

185.00%340.00K

43.89%1.07M

-27.05%631.00K

-115.67%-141.00K

-159.70%-400.00K

33.27%745.00K

101.16%865.00K

-39.84%900.00K

498.81%670.00K

-30.56%559.00K

-62.67%430.00K

-38.18%1.50M

-114.79%-168.00K

-26.48%805.00K

9.82%1.15M

83.47%2.42M

-21.33%1.14M

--1.09M

72.53%1.05M

--1.32M

--1.44M

--608.00K

Change in working capital

11.84%-8.19M

-1.00%-8.20M

-32.52%-6.94M

20.08%-7.72M

-0.34%-9.28M

1.44%-8.12M

71.70%-5.23M

-12.43%-9.66M

-41.20%-9.25M

-33.54%-8.24M

-1516.23%-18.50M

-25.76%-8.59M

-102.23%-6.55M

-117.30%-6.17M

16.30%1.31M

-1201.94%-6.83M

7514.44%293.24M

389.07%35.65M

-93.89%1.12M

--620.00K

-326.39%-3.96M

--7.29M

--18.39M

--1.75M

-Change in receivables

----

--0.00

-100.00%0.00

100.00%0.00

--0.00

--300.00M

---300.00M

----

-Change in prepaid expenses

-108.51%-91.00K

59.50%-501.00K

75.95%1.34M

97.85%920.00K

-19.50%1.07M

-122.48%-1.24M

13.41%761.00K

278.16%465.00K

49.72%1.33M

59.56%-556.00K

-39.50%671.00K

-16.00%-261.00K

382.07%887.00K

35.45%-1.38M

175.19%1.11M

-208.17%-225.00K

162.37%184.00K

27.67%-2.13M

142.38%403.00K

--208.00K

-360.94%-295.00K

---2.94M

---951.00K

---64.00K

-Change in other current liabilities

45.10%-3.27M

-223.77%-9.25M

-4.43%-8.15M

-9.71%-7.56M

-17.84%-5.95M

50.49%-2.86M

55.33%-7.81M

-23.04%-6.89M

4.88%-5.05M

-37.92%-5.77M

-969.65%-17.48M

-24.70%-5.60M

-35.43%-5.31M

-101.24%-4.18M

-3885.37%-1.63M

-1509.32%-4.49M

-1270.63%-3.92M

134396.02%337.08M

-100.28%-41.00K

---279.00K

---286.00K

---251.00K

--14.82M

--0.00

Cash from non-recurring investing activities

Cash from operating activities

-5.42%-25.27M

9.17%-22.27M

10.21%-18.86M

17.77%-21.00M

18.32%-23.97M

10.97%-24.52M

22.80%-21.00M

20.63%-25.54M

5.89%-29.34M

4.78%-27.54M

-36.15%-27.21M

-10.90%-32.17M

-111.48%-31.18M

-343.43%-28.92M

2.52%-19.99M

-56.97%-29.01M

1273.09%271.53M

211.52%11.88M

-852.09%-20.50M

---18.48M

-115.08%-23.15M

---10.65M

--2.73M

---10.76M

Investing cash flow

Net cash from continuing investing activities

-100.00%0.00

29.41%22.00K

-72.28%28.00K

1194.59%479.00K

281.48%309.00K

-96.38%17.00K

-84.12%101.00K

-86.25%37.00K

-75.45%81.00K

28.85%469.00K

157.49%636.00K

236.25%269.00K

43.48%330.00K

-69.89%364.00K

-86.23%247.00K

-98.89%80.00K

-95.76%230.00K

--1.21M

75.71%1.79M

--7.24M

--5.42M

--1.02M

Capital expenditures

-100.00%0.00

29.41%22.00K

-72.28%28.00K

1194.59%479.00K

276.83%309.00K

-96.38%17.00K

-84.12%101.00K

-86.25%37.00K

-75.15%82.00K

28.85%469.00K

157.49%636.00K

236.25%269.00K

43.48%330.00K

-69.89%364.00K

-86.23%247.00K

-98.93%80.00K

-95.76%230.00K

--1.21M

75.71%1.79M

--7.49M

--5.42M

--1.02M

Net cash flow from disposal of fixed assets

-100.00%0.00

29.41%22.00K

-72.28%28.00K

1194.59%479.00K

281.48%309.00K

-96.38%17.00K

-84.12%101.00K

-86.25%37.00K

-75.45%81.00K

28.85%469.00K

157.49%636.00K

236.25%269.00K

43.48%330.00K

-69.89%364.00K

-86.23%247.00K

-98.89%80.00K

-95.76%230.00K

--1.21M

75.71%1.79M

--7.24M

--5.42M

--1.02M

Net cash flow from investment products

-160.21%-17.72M

-41.89%13.23M

158.31%35.57M

288.53%33.86M

8.21%29.43M

-39.16%22.77M

-258.43%-61.01M

-145.35%-17.96M

-9.77%27.20M

699.92%37.42M

-16.98%38.51M

131.91%39.60M

118.94%30.14M

-163.96%-6.24M

198.48%46.38M

-258.49%-124.09M

-10749.49%-159.16M

110.49%9.75M

---47.10M

--78.30M

---1.47M

---92.98M

----

--0.00

Net cash flow from other investing activities

--0.00

----

---1.00K

----

Cash from non-current investing activities

Net cash flow from investing activities

-160.27%-17.72M

-40.64%13.23M

158.02%35.57M

288.23%33.83M

8.51%29.40M

-40.37%22.29M

-259.57%-61.31M

-145.93%-17.98M

-8.17%27.09M

674.54%37.38M

-16.56%38.43M

131.44%39.13M

118.51%29.50M

-167.27%-6.51M

197.30%46.05M

-261.45%-124.46M

-4788.35%-159.41M

109.65%9.67M

-772.41%-47.33M

--77.09M

-219.39%-3.26M

---100.22M

---5.42M

---1.02M

Financing cash flow

Cash flow from continuous financing activities

35707.19%49.77M

14425.00%581.00K

-95.34%49.00K

-99.75%254.00K

-88.09%139.00K

-97.85%4.00K

-24.22%1.05M

100100.00%103.21M

1044.12%1.17M

1062.50%186.00K

316.52%1.39M

-90.00%103.00K

-73.44%102.00K

-99.93%16.00K

-34.06%333.00K

827.93%1.03M

519.35%384.00K

-83.08%21.74M

-98.76%505.00K

--111.00K

-74.90%62.00K

--128.51M

--40.75M

--247.00K

Net cash flow from debt Issuance/repayment

----

-544.55%-21.20M

100.00%0.00

----

--4.77M

---500.00K

----

Net cash flow from common stock issuance/repurchase

--50.00M

--540.00K

--0.00

----

--0.00

--103.40M

----

--122.12M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

----

--0.00

--41.92M

----

Proceeds from stock option exercised by employees

-35.97%89.00K

925.00%41.00K

-96.60%49.00K

--254.00K

-88.09%139.00K

-97.85%4.00K

3.89%1.44M

-100.00%0.00

1044.12%1.17M

1062.50%186.00K

316.52%1.39M

-90.00%103.00K

-73.44%102.00K

-97.84%16.00K

-34.06%333.00K

827.93%1.03M

519.35%384.00K

100.54%740.00K

-12.63%505.00K

--111.00K

-74.90%62.00K

--369.00K

--578.00K

--247.00K

Net cash flow from other financing activities

---316.00K

--0.00

100.00%0.00

----

--0.00

---390.00K

---195.00K

----

3279.10%42.20M

----

--1.25M

---1.25M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

35707.19%49.77M

14425.00%581.00K

-95.34%49.00K

-99.75%254.00K

-88.09%139.00K

-97.85%4.00K

-24.22%1.05M

100100.00%103.21M

1044.12%1.17M

1062.50%186.00K

316.52%1.39M

-90.00%103.00K

-73.44%102.00K

-99.93%16.00K

-34.06%333.00K

827.93%1.03M

519.35%384.00K

-83.08%21.74M

-98.76%505.00K

--111.00K

-74.90%62.00K

--128.51M

--40.75M

--247.00K

Net cash flow

Beginning cash balance

47.17%84.13M

55.90%92.58M

-46.09%75.82M

-22.51%62.73M

-30.33%57.16M

-17.54%59.39M

136.75%140.66M

54.66%80.96M

52.15%82.04M

-19.39%72.01M

-5.61%59.41M

-75.69%52.35M

-47.58%53.92M

49.96%89.34M

-50.40%62.94M

215.89%215.38M

8.82%102.87M

-22.52%59.57M

226.73%126.90M

--68.18M

447.83%94.53M

--76.89M

--38.84M

--17.25M

Current period cash flow changes

21.81%6.79M

-280.31%-8.46M

120.63%16.76M

-78.07%13.09M

614.50%5.57M

-122.17%-2.22M

-744.84%-81.27M

745.28%59.69M

31.15%-1.08M

128.32%10.03M

-52.26%12.60M

104.63%7.06M

-101.40%-1.57M

-181.80%-35.41M

139.21%26.40M

-359.62%-152.44M

527.04%112.51M

145.52%43.30M

-276.91%-67.33M

--58.72M

-128.38%-26.35M

--17.63M

--38.05M

---11.54M

Ending cash balance

44.92%90.91M

47.17%84.13M

55.90%92.58M

-46.09%75.82M

-22.51%62.73M

-30.33%57.16M

-17.54%59.39M

136.75%140.66M

54.66%80.96M

52.15%82.04M

-19.39%72.01M

-5.61%59.41M

-75.69%52.35M

-47.58%53.92M

49.96%89.34M

-50.40%62.94M

215.89%215.38M

8.82%102.87M

-22.52%59.57M

--126.90M

1092.20%68.18M

--94.53M

--76.89M

--5.72M

Free cash flow

-5.29%-25.27M

10.91%-22.27M

11.51%-18.86M

17.73%-21.02M

18.51%-24.00M

9.36%-25.00M

21.90%-21.31M

21.72%-25.55M

7.45%-29.45M

5.53%-27.58M

-34.34%-27.29M

-11.12%-32.64M

-111.73%-31.82M

-347.36%-29.19M

2.01%-20.32M

-49.18%-29.38M

1187.72%271.29M

165.05%11.80M

-668.14%-20.73M

---19.69M

-111.67%-24.94M

---18.14M

---2.70M

---11.78M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Foghorn Therapeutics Inc. Generate?



Foghorn Therapeutics Inc. generated -86.10M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Foghorn Therapeutics Inc.'s Operating Cash Flow Change Year Over Year?



Foghorn Therapeutics Inc.'s operating cash flow increased by 14.25% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Foghorn Therapeutics Inc. Spend on Capital Expenditures?



Foghorn Therapeutics Inc. spent 50.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Foghorn Therapeutics Inc.'s Financing Cash Flow Changed?



Foghorn Therapeutics Inc. used 1.02M in financing activities in the latest quarter.

What is free cash flow and why does it matter for FHTX?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Foghorn Therapeutics Inc.’s free cash flow in the latest quarter?



Free cash flow was -86.15M reflecting a 14.97% change from the previous year.